Beam Therapeutics Inc (BEAM) earnings · rev $139.7M
These earnings events as JSON? API free 100/dayBeam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
This BEAM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BEAM revenue for 2025-12-31 was $139.7M. Net income was -$80.0M. Revenue was up 120.0% from 2024-12-31 to 2025-12-31. BEAM currently screens at market cap $2.01B.
When the next BEAM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 120.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BEAM research stays on the stock page; the tape stays on the quote page.
BEAM earnings FAQ
What are BEAM's latest revenue and net income?
Latest cached Beam Therapeutics Inc (BEAM) revenue for Dec 31, 2025 was $139.7M. Net income was -$80.0M. Statements: https://lician.com/financials/beam
What is BEAM's latest diluted EPS?
Latest cached Beam Therapeutics Inc (BEAM) diluted EPS for Dec 31, 2025 was -$0.81.
What period does the latest BEAM earnings print cover?
The latest cached Beam Therapeutics Inc (BEAM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BEAM revenue change from the prior cached period?
Cached Beam Therapeutics Inc (BEAM) revenue was up 120.0% from $63.5M (Dec 31, 2024) to $139.7M (Dec 31, 2025). Statements: https://lician.com/financials/beam
Where are BEAM earnings listed?
Cached earnings facts for Beam Therapeutics Inc (BEAM) are listed at https://lician.com/earnings/beam. Statements: https://lician.com/financials/beam
Not investment advice.